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Abstract
Background: Despite the fact that genetic counseling in oncology provides information regarding
objective risks, it can be found a contrast between the subjective and objective risk.
The aims of this study were to evaluate the accuracy of the perceived risk compared to the
objective risk estimated by the BRCApro computer model and to evaluate any associations
between medical, demographic and psychological variables and the accuracy of risk perception.
Methods: 130 subjects were given medical-demographic file, Cancer and Genetic Risk Perception,
Hospital Anxiety-Depression Scale. It was also computed an objective evaluation of the risk by the
BRCApro model.
Results: The subjective risk was significantly higher than objective risk. The risk of tumour was
overestimated by 56%, and the genetic risk by 67%. The subjects with less cancer affected relatives
significantly overestimated their risk of being mutation carriers and made a more innacurate
estimation than high risk subjects.
Conclusion: The description of this sample shows: general overestimation of the risk, inaccurate
perception compared to BRCApro calculation and a more accurate estimation in those subjects
with more cancer affected relatives (high risk subjects). No correlation was found between the
levels of perception of risk and anxiety and depression. Based on our findings, it is worth pursuing
improved communication strategies about the actual cancer and genetic risk, especially for subjects
at "intermediate and slightly increased risk" of developing an hereditary breast and/or ovarian
cancer or of being mutation carrier.
Background
Oncological genetic counseling enables to discover a
hereditary component which increases the risk of devel-
oping a tumour. The concept of risk is particularly impor-
tant in this process.
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jectively through the perception that a single individual
has of the risk. Alternatively, it can be measured objec-
tively using well-defined parameters.
In oncological genetic counseling, two reasons make it
important to measure the objective risk of having a
genetic mutation which increases the risk of developing a
tumour: it makes it possible to carry out a mutation anal-
ysis only on eligible people and also creates suitable pre-
vention programmes for different levels of risk.
Subjective risk assessment has also a great importance
because it influences decisions on whether to undergo
genetic testing or not [1-3], on whether to participate in
surveillance programmes [4,5], or to accept prophylactic
surgery [6-8]. It also influences levels of psychological dis-
tress [7,9,10].
Despite the fact that genetic counseling provides informa-
tion regarding objective risks, there is frequently a contrast
between the perception of the risk of developing a tumour
and being a carrier of a genetic mutation and the objective
risk [11,12]. These data imply that, apart from cognitive
factors, the perception of risk is also influenced by various
factors [13]. Literature evidenced that, age, together with
other socio-demographic factors, as for example the edu-
cation, the employment or the spirituality influenced
moderately the risk perception. Some studies stated that
younger women are more likely to perceive higher risk of
developing breast cancer then older, while other studies
concluded no significant relationship between age and
perceived risk [14]. Only one study reported that
employed women were more likely to overestimate their
risk compared to their actual risk [15]. Findings on the
relation between education and perceived risk concluded
that women with high school or less education were more
likely to be either unaware of their risk or overestimate
their risk, whereas women with college education were
less likely to have an optimistic bias [14]. The role of reli-
gion in health care decisions and perceived risk among
people at increased genetic risk has not been deeply inves-
tigated yet. It exists a certain kind of religious fatalism (a
belief that some issues are beyond human control but just
in God's hands) that may influence the subjects' concep-
tions of how disease occurs and of how much they can be
at risk for developing a particular disease based on family
history [16,17]. On the basis of this kind of fatalism we
may hypothesize that the perception of the risk is lower
for subjects with high spirituality, as demonstrate by JM
Quillin research [17]. Furthermore many studies focused
on the role played by psychological distress levels and by
the personal and family history of tumour in filtering,
modifying and completing relevant information, concern-
ing the objective risk, affecting in this way the risk percep-
tion of developing the disease[11,12,14,18].
As regards the relationship between the psychological dis-
tress and the risk perception findings are opposing. In fact
several studies revealed a correlation between high dis-
tress levels and high risk perception, while few researches
showed no correlation between these two variables
[14,18].
As far as the family history of tumour is concerned,
women with a personal and a family history of cancer usu-
ally perceived their risk of developing the disease as higher
than that of other women. Nevertheless, comparing the
risk perception with an objective estimation of the risk
(Claus, Gail or BRCA-PRO models), the women affected
by cancer and with a family history of tumour are more
accurate in their risk estimation than women with a fam-
ily history of tumour but healthy [11,12]. Women
involved in several studies that revealed an overestima-
tion of the risk perception are usually referred by an
affected relative or by health care setting, while the studies
that found an underestimation of the risk perception
involved women referred by the community. The impor-
tance of risk perception in affecting the decisional making
process of the counselee and the relationship between the
risk perception and other psychological variables are key
issues in the research on genetic counselling across differ-
ent countries.
Nevertheless, in Italy, the risk perception has been little
studied and counselors still miss relevant information
like: how the risk perception is spread on Italian popula-
tion, how the risk is associated to other psycho-social var-
iables and if the risk perception is accurate or not
compared to objective methods of risk estimate[19].
The main aim of this research is to study the risk percep-
tion among a population enlisted by a department of
genetic counseling in the centre of Italy.
In particular, this study evaluates the perception levels of
the risk to be a mutation carrier and to develop a related-
cancer, the association between perceived risk and medi-
cal/demographic/psychological variables and the ade-
quacy of the perceived risk compared to the objective risk
estimated by BRCA-PRO model [20,21].
Methods
Participants
From February 2007 to November 2008, 153 subjects
were submitted to genetic counseling at the Unit forPage 2 of 11
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Elena" National Cancer Institute of Rome. The analysis
was carried out on a sample of 130 subjects who had can-
cer of the breast and/or ovaries and/or a family history of
tumours (at least one first-degree affected relative).
Twenty-one subjects did not complete the questionnaires
and psychological tests, two were illiterate.
Genetic counseling procedures
Subjects who requested counseling to the Unit for Hered-
itary Breast and/or Ovarian Tumours of "Regina Elena"
National Cancer Institute of Rome were referred by their
physician or came spontaneously under suggestion from
relatives, friends, other oncologic patients or mass media
information.
The counseling multidisciplinary team included an oncol-
ogist/counselor, psychologist, and geneticist. The coun-
seling modalities were designed using a multistep
approach as follows:
During the first visit the oncologist/counselor, supported
by the psychologist, supplied the patient with informa-
tion about hereditary cancer syndromes, the mutation of
BRCA1/BRCA2 genes, and their involvement in the onset
of cancer of the breast and/or ovaries. Further information
is supplied regarding transmission, the possibility of pre-
vention and treatment.
Afterwards, the physician asked the patient to sign in an
informed consent to collect the family history in order to
assess the genetic and cancer risk estimation.
Furthermore, risk estimation and eligibility or non eligi-
bility status for genetic test was also performed following
the Modena Criteria [[22,23], http://www.com.unimo.it/
com2000/hbc/alberi/lineeg.htm].
Applying these criteria, subjects were classified as eligible
if they were at "high risk", or non eligible if they resulted
at "intermediate, or slightly increased risk", as described
in Table 1. Only the eligible subjects were proposed to
Table 1: Modena Model
High risk Pedigree Classification
I) at least 3 relatives 
diagnosed with BC (or OC) 
in 2 different generations
II) one BC/OC case is a first 
degree relative of the other 
2 (of the other 1 if the first 
criterion is not fulfilled)°
III) at lest one case has 
been diagnosed at the age 
≤ 40 or with bilateral BC
* * * Hereditary HBC/HBOC
* * Suspect Hereditary SHBC/SHBOC
* * Suspect Hereditary SHBC/SHBOC
BC diagnosed at age ≤ 35, 
regardless of family history
Early onset EOBC
BC and OC in the same woman, 
regardless of family history
Breast and Ovarian Cancer BOC
Intermediate Risk
* Familial FBC/FBOC
* * Strongly suspected Familial SFBC/SFBOC
Male BC, regardless of family history Male Breast Cancer MBC
Slightly Increased Risk
* Suspected Familial SFBC/SFBOC
* Suspected Familial SFBC/SFBOC
BC/OC without any of the described criteria Sporadic Breast Cancer SpBC/SpOC
BC - Breast Cancer; OC - Ovarian Cancer; H - Hereditary; F- Familial; S - Suspect; s - sporadic; M - MalePage 3 of 11
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after 14 days. This lapse of time was chosen to give sub-
jects the time to elaborate the information and to decide
with greater awareness.
During the second visit the oncologist/counselor, sup-
ported by the psychologist, asked the patient his/her con-
sent for the blood sample.
After six months the subjects knew the genetic test result.
During this third visit the physician and the psychologist
together communicated the outcome of the test, the pos-
sible involvement of the family into genetic counseling
and the risk-reducing strategies, they help the subjects to
express emotions, doubts, and requests focused on the
genetic test outcome and on how to communicate the
outcome to the sibling or children [24,25].
The local Ethic Committee approved the counseling pro-
cedures.
At the end of each counseling session the psychologist
asked to the patients an informed consent to complete
questionnaires and psychological tests.
During the second counseling step, only eligible subjects
were proposed to give the blood sample; while for the
others or non eligible subjects were organized an "ad hoc"
surveillance programmes. This study refers to the data
obtained by the questionnaires completed after the first
genetic counseling session by 130 subjects. The sample
was made up of eligible and non eligible subjects.
Instruments
The questionnaires and psychological tests evaluate the
following variables.
Demographic and medical characteristics
Data regarding age, geographic origin, civil status, number
of children, education, religion and whether they were
religious-practicing or non-practicing, eligibility, pathol-
ogy, number of relatives affected by cancer of the breast
and/or ovaries and the total number of relatives affected
by any type of tumour were collected.
Cancer Risk Perception (CRP)
An item adapted from previous research was used to eval-
uate the perception of the risk of developing a tumour:
"Indicate with a cross, on a scale from 0 to 100, that which
you think is your current percentage risk of developing a
tumour, or redeveloping a tumour of the breast and/or
ovaries" [26,17].
The answer was given on a visual analogue scale from 0 to
100 (100 corresponds to the highest risk). The scale is a
ten centimetres line and each millimetre corresponds to
one point percent.
Genetic Risk Perception (GRP)
An item adapted from previous research was used to eval-
uate the perception of the risk of being a carrier of the
genetic mutation BRCA1/BRCA2 [10]. "Indicate with a
cross, on a scale from 0 to 100, which you think is your
current percentage of being a carrier of the genetic muta-
tion which causes cancer of the breast and/or ovaries." The
answer was given on a visual analogue scale from 0 to
100% (100 corresponds to the highest risk). The scale is a
ten centimetres line and each millimetre corresponds to
one point percent.
Objective cancer and genetic risk assessment by BRCAPRO model
Data of the family pedigree were inserted (in a separate
moment without the presence of consultant) into the
computer programme "Cancer-Gene-Program" (that is
based on the BRCAPRO evaluation model) to evaluate the
risk of being a carrier of the BRCA1/BRCA2 mutation and
the risk to develop breast and/or ovarian
tumour[20,27,28].
This programme uses Mendelian genetics and the Bayes
theory to estimate risk considering the following factors:
the number of relatives affected and not affected by a
tumour of the breast and/or the ovaries, age at onset,
number of generations affected, tumour of the breast in
men. The final estimation results are two percent values,
one for the risk of being a carrier mutation and one for the
risk to develop a tumour. This model has been used on
large samples and in many countries. It considers factors
which other models omit, and its validity and sensibility
(by identifying subjects with probable genetic mutation)
has been demonstrated in six centres of genetic consulting
[19,29,30]. This software is easily available via the inter-
net and it is also user-friendly. The last version is
CaGene5, available from the official web site: http://
www8.utsouthwestern.edu/utsw/cda/dept47834/files/
67943.html.
Accuracy of the perception of risk
The percentage risk of developing a tumour and of being
a carrier of a genetic mutation evaluated by BRCAPRO
were compared to the percentage of perceived risk in order
to assess the adequacy of the perceived risk compared to
the objective risk (more details in the statistical methods
section).
Anxiety and Depression
The Hospital Anxiety and Depression Scale (HADS) [31],
Italian version [32] is used in literature to evaluate the
psychological distress in a non-psychiatric setting. It is
composed of two scales of 14 items, 7 regarding anxietyPage 4 of 11
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lated separately with three cut-offs: normal anxiety and
depression (0-7), borderline anxiety and depression (8-
10), disturbance due to anxiety and depression (≥11). By
calculating the sum of the two scales, it is possible to iden-
tify the presence of disturbance in adaptation(cut-off 13-
18), or an episode of heavy depression (cut-off ≥ 19). No
psychological distress is evidenced if the sum of the two
scores totals <13.
All instruments used were chosen on the basis of the fol-
lowing characteristics: validation, internal reliability and
previous use in literature for populations comparable to
the one from which the sample for the present study was
drawn.
Statistical methods
Descriptive statistics were used to summarize pertinent
study information.
The association between variables was tested by the Pear-
son Chi-Square test.
A paired sample t-test was used to compare the mean val-
ues of the subjective perception of risk, with the objective
risk, estimated by BRCAPRO.
The percentage risk of developing a tumour and of being
a carrier of a genetic mutation evaluated by BRCAPRO
were compared to the percentage of perceived risk in order
to assess the adequacy of the perceived risk compared to
the objective risk. To make this comparison, Bluman et al.
in 1999 [33] calculated the quartiles (≤ 25%, 26%-50%,
51%-75%, ≥ 76%) of both the percentage values of objec-
tive and subjective risk and after that they make a compar-
ison between the two values. The variable, resulting from
this comparison, categorizes the subjects in overestima-
tors, accurate estimators and underestimators.
Differences between groups ("corrected", "under" and
"over" estimators) with Kruskal-Wallis non parametric
test were analyzed for age, number of relatives affected by
cancer and for distress levels.
Concordance between the subjective perception of risk
and the objective risk estimated by BRCAPRO was
assessed using Cohen's k coefficient of agreement [34].
Landis and Koch proposed categories for judging K values:
K less than 0.0 was considered poor, 0.00 to 0,20 was
light, 0.21 to 0.40 was fair, 0.41 to 0.60 was moderate,
0.61 to 0.80 was substantial and 0.81 to 1.00 was perfect
[35]. Given ratings on a K-level categorical variable, the
marginal homogeneity test was used for calculated agree-
ment between two rates summarized by a K × K cross-clas-
sification table.
Given the small numbers, statistical analyses cannot be
performed to assess the differences between male and
female in risk perception. The SPSS (11.0) statistical pro-
gram was used for the analyses.
Results
Description of the sample
The average characteristics of the sample of 130 subjects
(women/men = 119/11) are reported in Table 2 and 3.
Subjective and objective risk
The mean percentage regarding the subjective risk of
developing a tumour and of being a carrier of the genetic
mutation were 39% and 40%, respectively.
The mean percentage regarding the objective risk, calcu-
lated using the BRCAPRO model, of developing a tumour
and of being a carrier of the genetic mutation were 11%
and 19%, respectively.
Anxiety and Depression
The total mean score was 13, with 24% of the subjects suf-
fering one episode of major depression and 19% experi-
encing the presence of some disturbance in adaptation.
A mean score of 8 was found for the single scales (border-
line anxiety) and of 5 (normal depression). A total of 25%
had borderline anxiety levels and the same value was
found in subjects suffering from anxiety.
Depression was found in 9% of the subjects, while 15%
were borderline.
Association between medico-demographic variables and 
risk perception (table 4 and 5)
Of all the medical-demographical variables, only the con-
dition of eligibility was found to be statistically associated
to the perception of risk (Table 4).
The subjects who were eligible for genetic testing had a
significantly higher perception of risk compared to the
non-eligible people (CRP = 43%vs33%, p = 0.024; GRP =
46%vs29%, p < 0.000).
Despite the fact that the pathology was not found to be
associated with the perception of risk, the affected subjects
were found to have higher percentages than healthy sub-
jects (CRP = 41%vs39%, P = 0.712; GRP = 45%vs38%, P
= 0.108).
Associations between psychological distress and risk 
perception (table 5)
No correlation was found between the levels of percep-
tion of risk and anxiety (CRP r = 0.050 p = 0.60;GRP r =Page 5 of 11
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Table 2: Descriptive results
N = 130 subjects
Women/Men = 119/11
Median Range
Age 47 19-77
Number of relatives affected by tumours of the breast and/or ovaries 2 0-6
Number of relatives affected by other types of tumour 4.5 0-18
Frequency %
Geographical Area of Origin
Central Italy 100 77
Other areas (South-North-Abroad) 30 23
Civil Status
Single 58 44.6
Married 72 55.4
Number of children
No children 43 33.1
1 child 26 20
+ children 61 46.9
Education
Primary (age 5 to 14) 27 20.8
High school (age 14 to 19) 65 50
University 38 29.2
Profession
Worker 87 66.9
Unemployed 43 33.1
Eligibility
Eligible 81 62.3
Non-eligible 49 37.7
Pathology
Affected 42 32.3
Non-affected 88 67.7
Journal of Experimental & Clinical Cancer Research 2009, 28:157 http://www.jeccr.com/content/28/1/1570.087 p = 0.35) and depression (CRP r = -0.31 p =
0.74;GRP r = 0.072 p = 0.53).
No correlation was discovered between distress levels and
family history of tumour (r = 0.050 p = 0.60).
No significant differences in distress levels were revealed
between affected and non-affected subjects (Distress =
12.42 vs 13.32 p = 0.46) and between eligible and non-
eligible subjects (Distress = 18.82 vs 13.37). However, the
non-affected and the non-eligible subjects were above the
cut-off point of disturbance in adaptation.
Associations between objective and subjective risks 
(table 5)
The subjective risk was found to be correlated to objective
risk BRCApro (CRP r = 0.254 p = 0.006; GRP r = 0.322 p
< 0.000).
However, the percentage levels of subjective risk were
found to be significantly higher than for objective risk
(CRP = 39%vs11%, p < 0.000; GRP = 40%vs19%, p <
0.000).
Accuracy of the perception of risk (table 3)
Compared to the objective risk a significant percentage of
individuals overestimated the risk of developing a tumour
(57%, p < 0.000), while only 11% underestimated the
risk. The remaining 32% made an accurate estimation.
Concerning the risk of being a carrier of the genetic muta-
tion a significant number of subjects overestimated the
risk (67%, p < 0.000), while 7% underestimated it and
26% had an accurate perception.
Eligible subjects made a significantly more accurate esti-
mate of their risk compared to non-eligible ones, CRP(P =
0.001) and GRP (P = 0.006).
Discussion
The subjects with less cancer affected relatives significantly
overestimated their risk of being mutation carrier (p =
0.028). No association was found between other medical-
demographic or psychological variables and the accuracy
of the risk estimate.
The results show that most of the sample overestimated
their cancer and genetic risk. This Italian sample, under
this aspect, does not differ from samples of subjects with
higher risk of breast cancer and/or ovary tumours from
other countries, like Spain [17], United Kingdom [36],
USA [10], Netherlands [7] and Australia [37].
The relevant overestimation of risk leads to the belief that
information gathered during counseling sessions does not
adequately reach the patient, as elsewhere reported in lit-
erature [5,38,39].
However, in the present study this misunderstanding
seems to be associated to eligibility conditions and to the
number of cancer affected relatives. Indeed, the subjects
with a high family history of tumour (usually the eligible
subjects for genetic testing) seem to underestimate or
make an accurate estimation of their risk, while subjects
with at least one affected relative, but not eligible (Inter-
mediate or Slightly increased risk), had a percentage of
overestimate of risk significantly higher. Our hypothesis is
that the subjects eligible for a genetic test, having a high
number of relatives affected by tumours and often
stricken themselves, are not only more open to informa-
tion regarding their risk, but also more aware in compari-
son to subjects with familiarity or with sporadic events of
breast and/or ovarian tumours in their family [10,14,40].
Table 3: Descriptive results
Mean Range
Anxiety 7.9 0-16
Depression 5.1 0-15
Cancer Risk Perception* 38.9 0-100
Genetic Risk Perception** 39.9 0-86.8
BRCA pro Cancer Risk 10.6 0-99.1
BRCA pro Genetic Risk 18.7 0.10-66.5
Frequency %
Adequacy of the cancer risk perception
Overestimation 65 56.9
Adequate Estimation 38 31.9
Underestimation 13 11.2
Adequacy of the genetic risk perception
Overestimation 77 66.9
Adequate Estimation 30 26.1
Underestimation 8 6.9
*14 subjects were unable to report their risk levels for cancer of the 
breast and/or ovaries
**15 subjects were unable to report their level of risk of being a 
carrier of the genetic mutation of the BRCA1 and BRCA2 genesPage 7 of 11
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Table 4: Associations between the perception of risk (CRP-GRP) and Medical-Demographic variables
N Mean Std. Deviation P
(2-tailed)
ELIGIBILITY
Cancer Risk Perception
Non-Eligible 44 32.82 21.87
Eligible 72 43.04 24.13 .024*
Genetic Risk Perception
Non-Eligible 43 29.11 21.92
Eligible 72 46.45 21.96 .000*
PATHOLOGY
Cancer Risk Perception
Non-Affected 84 38.63 21.14
Affected 32 40.89 30.35 .712
Genetic Risk Perception
Non-Affected 83 37.90 22.99
Affected 32 45.23 23.74 .108
Table 5: Associations between the perception of risk (CRP-GRP) and Medical-Demographic and Psychological variables
Cancer risk perception Genetic risk perception
Anxiety
Pearson coefficient 0.050 0.087
P (2-tailed) 0.596 0.355
Depression
Pearson coefficient -.031 .072
P (2-tailed) .742 .537
Age
Pearson coefficient -.068 -.030
P (2-tailed) .468 .747
Number of relatives affected by breast and/or ovarian cancer
Pearson coefficient .053 -.082
P (2-tailed) .569 .386
Number of relatives affected by other types of tumour
Pearson coefficient -.149 -.139
P (2-tailed) .111 .140
BRCA pro Cancer Risk
Pearson coefficient .254
P (2-tailed) .006 ---
BRCA pro Genetic Risk
Pearson coefficient .322
P (2-tailed) --- .000
Journal of Experimental & Clinical Cancer Research 2009, 28:157 http://www.jeccr.com/content/28/1/157As far as the association between psychological variables
and risk perception is concerned, some studies evidenced
that there is a positive correlation between the perception
of risk and levels of psychological distress. However, in
this study, no such correlation was found, despite the fact
that the psychological distress levels reached the cut-off
value of disturbance in adaptation. We do not have an
Italian regulatory sample of reference for HADs which
considers not only subjects with tumours but also healthy
subjects. However, in a population of women with breast
cancer the percentage of subjects unable to adapt to the
situation was of 24% (19% in our sample) and of 9,8%
with at least an episode of major depression (24% in our
sample) [32]. These two scores, as set forth in the meth-
ods, are obtained adding the score of each individual
measure of anxiety and depression. Taking this into con-
sideration, it is interesting to note that in our sample the
raising of the percentage of the subjects with at least one
episode of major depression, with respect to regulatory
samples (24% vs 9.8%), derives from the elevation of the
anxiety scale: 25% of borderline anxiety samples and 25%
with anxiety disorders. Despite the fact that a high psycho-
logical distress is shown, mainly consisting of an element
of anxiety, there is no association between the risk percep-
tion "per se" and anxiety or depression levels and neither
between the accuracy of risk perception and anxiety or
depression levels.
This could depend on the fact that the HAD's scale,
although largely used in genetic counseling for hereditary
tumours, reveal a type of "general" psychological distress
linked to a pathological event rather than a "cancer-spe-
cific" distress.
Punctual correlations between distress and perception lev-
els found in literature has been evidenced through the use
of cancer-specific instruments (for measuring distress lev-
els due to cancer worries) such as the Cancer Worry Scale
of Lerman, or the Impact of Event Scale of Horowitz
[36,41]. The latter can be adapted for a kind of distress
due to specific pathologies. Unfortunately, these tests are
not still validate in all country - specific languages, (i.e.
Lerman test is actually under validation in Italian Lan-
guage through a multi-cohort research project coordi-
nated by the National Committee PSICONCOGEN of
Italian Society of Psycho-Oncology) and the experiences
about the use of cancer - specific questionnaires in genetic
counseling in Italy doesn't exist yet.
As set forth in the introduction section we suppose that
the spirituality has a negative correlation with the risk per-
ception. No difference has arisen between religious and
non-religious subjects; however, one have to consider as a
limit the measure of religion and religiosity which is not
overtly articulated and thorough as far as prayers and the
degree of emotional and cognitive involvement in these
rites are concerned.
Limitations
Limitations to the current study should be noted. To
begin, it is important to take into consideration the self-
selection bias. The general overestimation of the risk can
be due, from one part to the self-referral way of inclusion
in the study and to the other part, to the fact that all the
eligible subjects for this study had almost one first degree
relative affected by cancer of the breast or ovaries. In
actual fact, the subjects of this study asked for a visit
because they thought their chances of having a mutation
and/or their breast cancer risk was high. Secondly, the
BRCAPRO evaluation model can introduce some limita-
tion (that is an underestimation of the risk), not consider-
ing in the calculation of the risk relatives with less than
first degree of kinship. Moreover, the instrument used to
measure the perceived risk, the numerical visual analogue
scale, sometimes lead the patients to overestimate their
own risk [13].
Thirdly, it could be difficult to know how generalizable
these results from a select sample of subjects coming from
the centre of Italy are to populations that come from other
parts of Italy or to other ethnic groups.
Conclusions
In Italy, where health care is mainly a public service con-
cern, and cancer genetic counseling is a relatively new con-
cept and is almost invariably offered within the
framework of clinical research units, the variable "percep-
tion of risk" has been very little investigated [18].
The present study attempts to describe the perception of
risk in subjects who have requested oncological genetic
counseling in a sample of Central Italy. The results are
similar to other studies carried out in other countries in
the following ways: general overestimation of the risk,
inaccurate perception compared to systems of objective
calculation and an underestimation or more accurate esti-
mation in those subjects with eligibility criteria.
Practice Implications
From information derived from this study we find that the
doctors working in the oncological genetic counseling in
Italy, as well in other countries, are face an exacting task to
impart information to people who often have high anxi-
ety levels (they do not usually reach pathological limits)
and an exaggerated perception of personal risk of having
a genetic mutation and/or a tumour. In particular we
found that the misperception of the risk is higher for the
subjects with familiarity or with sporadic events of breast
and/or ovarian tumours in their family (at intermediate or
slightly increased risk, Table 1). For that reason it appearsPage 9 of 11
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tional point of view, must be paid both by the physicians
and the psychologist especially for these target of subjects
(at intermediate or slightly increased risk, Table 1). It
might be important that physicians verify, step by step,
the level of consultants understanding, asking consultants
opinions and facilitating answers or doubts regarding the
familial risk information. Psychologist, might facilitate
this communication between consultant and physician.
Moreover, during the psychlogical talk, it might also facil-
itate the awareness process which necessary involves cog-
nitive and emotional aspects concerning the cancer and
genetic risk information.
Reported data were collected after the first genetic coun-
seling session and cannot therefore be subsequently
checked. It is our intention to await until data relative to
psychological follow-up after counseling are completed
that is to say 48 months after the outcome of genetic test
with the aim to evaluate the evolution of the psychologi-
cal impact of genetic counseling as well as to assess the
possibility of new or improved interventions.
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